139 related articles for article (PubMed ID: 22790551)
1. Clinical investigations for SUS, the Brazilian public health system.
Paula AP; Giozza SP; Pereira MZ; Boaventura PS; Santos LM; Sachetti CG; Tamayo CO; Kowalski CC; Elias FT; Serruya SJ; Guimarães R
Sao Paulo Med J; 2012; 130(3):179-86. PubMed ID: 22790551
[TBL] [Abstract][Full Text] [Related]
2. Landscape of Brazilian research and development public funding in advanced therapies: lessons learned and a roadmap for middle-income economies.
Sachetti CG; Júnior AB; de Carvalho ACC; Angulo-Tuesta A; da Silva EN
Cytotherapy; 2022 Nov; 24(11):1158-1165. PubMed ID: 35945103
[TBL] [Abstract][Full Text] [Related]
3. Direct from the COVID-19 crisis: research and innovation sparks in Brazil.
Rosa MFF; da Silva EN; Pacheco C; Diógenes MVP; Millett C; Gadelha CAG; Santos LMP
Health Res Policy Syst; 2021 Jan; 19(1):10. PubMed ID: 33478499
[TBL] [Abstract][Full Text] [Related]
4. Impact of health research on advances in knowledge, research capacity-building and evidence-informed policies: a case study on maternal mortality and morbidity in Brazil.
Angulo-Tuesta A; Santos LM; Natalizi DA
Sao Paulo Med J; 2016 Apr; 134(2):153-62. PubMed ID: 27224280
[TBL] [Abstract][Full Text] [Related]
5. [Health research in Brazil: context and challenges].
Guimarães R
Rev Saude Publica; 2006 Aug; 40 Spec no.():3-10. PubMed ID: 16924297
[TBL] [Abstract][Full Text] [Related]
6. Fulfillment of the brazilian agenda of priorities in health research.
Pacheco Santos LM; Moura EC; Barradas Barata Rde C; Serruya SJ; da Motta ML; Silva Elias FT; Angulo-Tuesta A; de Paula AP; de Melo G; Guimarães R; Grabois Gadelha CA
Health Res Policy Syst; 2011 Aug; 9():35. PubMed ID: 21884575
[TBL] [Abstract][Full Text] [Related]
7. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
[TBL] [Abstract][Full Text] [Related]
8. Defining and implementing a national policy for science, technology, and innovation in health: lessons from the Brazilian experience.
Guimarães R; Santos LM; Angulo-Tuesta A; Serruya SJ
Cad Saude Publica; 2006 Sep; 22(9):1775-85; discussion 1786-94. PubMed ID: 16917568
[TBL] [Abstract][Full Text] [Related]
9. Mapping the tuberculosis scientific landscape among BRICS countries: a bibliometric and network analysis.
Castor K; Mota FB; da Silva RM; Cabral BP; Maciel EL; de Almeida IN; Arakaki-Sanchez D; Andrade KB; Testov V; Vasilyeva I; Zhao Y; Zhang H; Singh M; Rao R; Tripathy S; Gray G; Padayatchi N; Bhagwandin N; Swaminathan S; Kasaeva T; Kritski A
Mem Inst Oswaldo Cruz; 2020; 115():e190342. PubMed ID: 32187325
[TBL] [Abstract][Full Text] [Related]
10. [National Health Innovation System: relations between scientific fields and economic sectors].
Pereira JC; Baltar VT; de Mello DL
Rev Saude Publica; 2004 Feb; 38(1):1-8. PubMed ID: 14963535
[TBL] [Abstract][Full Text] [Related]
11. [Use of health technology assessment in decision-making processes by the Brazilian Ministry of Health on the incorporation of technologies in the Brazilian Unified National Health System].
Novaes HM; Elias FT
Cad Saude Publica; 2013 Nov; 29 Suppl 1():S7-16. PubMed ID: 25402252
[TBL] [Abstract][Full Text] [Related]
12. Incentives and challenges related to technological research and innovation within the Unified Health System in the Federal District of Brazil.
Novaes MRCG; Motta MLD; Elias FTS; Silva RED; Silva CCGD; Baliero VAT; Tenorio M
Cien Saude Colet; 2019 Jun; 24(6):2211-2220. PubMed ID: 31269180
[TBL] [Abstract][Full Text] [Related]
13. Federal funding of health policy in Brazil: trends and challenges.
Machado CV; Lima LD; Andrade CL
Cad Saude Publica; 2014 Jan; 30(1):187-200. PubMed ID: 24627025
[TBL] [Abstract][Full Text] [Related]
14. National expenditure on health research in South Africa: How has the landscape changed in the past decade?
Barnabé MA; Gordon R; Ramjee G; Loots G; Blackburn JM
S Afr Med J; 2020 Mar; 110(4):274-283. PubMed ID: 32657738
[TBL] [Abstract][Full Text] [Related]
15. Health and innovation: economic dynamics and Welfare State in Brazil.
Gadelha CA; Braga PS
Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00150115. PubMed ID: 27828678
[TBL] [Abstract][Full Text] [Related]
16. Cancer research in Brazil - stuck in second gear?
Lepique AP; Bonorino C
Braz J Med Biol Res; 2015 Feb; 48(2):108-10. PubMed ID: 25590351
[TBL] [Abstract][Full Text] [Related]
17. Future health spending forecast in leading emerging BRICS markets in 2030: health policy implications.
Jakovljevic M; Lamnisos D; Westerman R; Chattu VK; Cerda A
Health Res Policy Syst; 2022 Feb; 20(1):23. PubMed ID: 35183217
[TBL] [Abstract][Full Text] [Related]
18. [An analysis of the Ministry of Health of Brazil investments in research and development between 2000-2002: a base line towards future valuations beginning with the implementation of the National Health Research Priority Agenda].
Caetano R; Vianna CM; Sampaio MM; da Silva RM; Rodrigues RR
Cien Saude Colet; 2010 Jul; 15(4):2039-50. PubMed ID: 20694326
[TBL] [Abstract][Full Text] [Related]
19. Flows of financial resources for health research and development in Brazil, 2000-2002.
Vianna CM; Caetano R; Ortega JA; Façanha LO; Mosegui GB; Siqueira M; Costa TB
Bull World Health Organ; 2007 Feb; 85(2):124-30. PubMed ID: 17308733
[TBL] [Abstract][Full Text] [Related]
20. [An analysis of financial flows from the Brazilian Ministry of Health for research and development in 2003-2005 according to the National Agenda for Health Research Priorities].
Silva RM; Caetano R
Cad Saude Publica; 2011 Apr; 27(4):687-700. PubMed ID: 21603752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
